User Stats

Level: Guru
Member Since: 08/09/2019

Profile Information

First name Qiao
Last name Qiao
I have professional experience in:

Seed funding, Venture capital, Biotech, Cancer therapeutics, Clinical trials, Diagnostics, Digital Health, Drug Delivery, Drug Discovery, Health tech, Medical Device, Oncology, Personalised medicine, Therapeutics, Veterinary Health, Business strategy, IP & Licensing, Market access, Startups, Technology transfer

Help us confirm that you're an expert

Qiao is an entrepreneurial life science business development professional. He is part of the team establishing the Torch Innovation Precinct at UNSW Sydney. Qiao is dedicated to building long-lasting high value cooperation with external partners, biotechnology and pharmaceutical companies and sophisticated equity investors. Currently, he manages a multi-million-dollar portfolio of UNSW biomedical technology comprising treatments for oncology, cellular therapy, infectious and metabolic diseases as well as in vitro diagnostic and implantable medical devices. He sits on the investment committee of UniSeed, an early-stage investment firm. Qiao completed his PhD (Medicine) at UNSW and was awarded BSc (Biotech) with first class honours from the University of Adelaide.

LinkedIn

http://www.linkedin.com/in/qiaoq

Base
Name

Qiao Qiao

I have professional experience in:

Seed funding, Venture capital, Biotech, Cancer therapeutics, Clinical trials, Diagnostics, Digital Health, Drug Delivery, Drug Discovery, Health tech, Medical Device, Oncology, Personalised medicine, Therapeutics, Veterinary Health, Business strategy, IP & Licensing, Market access, Startups, Technology transfer

Help us confirm that you're an expert

Qiao is an entrepreneurial life science business development professional. He is part of the team establishing the Torch Innovation Precinct at UNSW Sydney. Qiao is dedicated to building long-lasting high value cooperation with external partners, biotechnology and pharmaceutical companies and sophisticated equity investors. Currently, he manages a multi-million-dollar portfolio of UNSW biomedical technology comprising treatments for oncology, cellular therapy, infectious and metabolic diseases as well as in vitro diagnostic and implantable medical devices. He sits on the investment committee of UniSeed, an early-stage investment firm. Qiao completed his PhD (Medicine) at UNSW and was awarded BSc (Biotech) with first class honours from the University of Adelaide.

LinkedIn

http://www.linkedin.com/in/qiaoq